Here, we showed RBFOX2 target exons are differentially spliced between normal pancreas and pancreatic cancer, suggesting that alternative splicing of these exons is an integral part of pancreatic cancer progression. This evidence concerns the gene RBFOX2 and pancreatic neoplasm.